Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction.

Cardiovasc Diabetol · 2012 · PMC3489608 · PMID 23057687

Europe PMC DOI

hedged sentences

0.0660

closest p · 1.3× alpha

0.0660

boldest claim

The sentences

close to significancep = 0.066so close (0.05 < p ≤ 0.1)

Kaplan-Meier analysis of total mortality during one year was close to significance in favor of the combination (p = 0.066).

also in 2,130 other papers

highly significantno p-value reported

From a clinical point of view, in all available 5 randomized control trials beneficial effects of major fibrates (gemfibrozil, fenofibrate, bezafibrate) were clearly demonstrated and were highly significant in patients with atherogenic dyslipidemia.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.